# Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

**Authors:** Farrell A. Tobolowsky, Fred Nsubuga, Zunera Gilani, Annet Kisakye, Helen Ndagije, Daniel Kyabayinze, Jane F. Gidudu

PMC · DOI: 10.3201/eid3004.231361 · Emerging Infectious Diseases · 2024-04-01

## TL;DR

A new oral polio vaccine was tested for safety in Uganda in 2022 and found to be safe.

## Contribution

The study confirms the safety of a novel oral poliovirus vaccine type 2 during a large-scale immunization campaign.

## Key findings

- No safety signals were detected using passive and active surveillance methods.
- The vaccine was safely administered during a nationwide supplemental immunization activity.

## Abstract

Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of passive and active surveillance.

## Full-text entities

- **Chemicals:** Oral Poliovirus Vaccine 2 (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10977820/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10977820/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC10977820/full.md

---
Source: https://tomesphere.com/paper/PMC10977820